Mintaka Foundation receives Wellcome grant to get anti-HIV cream into clinic
This article was originally published in Scrip
Executive Summary
The Mintaka Foundation for Medical Research in Switzerland has been awarded around CHF4.5 million ($4.2 million) from the UK's biomedical research charity the Wellcome Trust to meet the remaining costs of bringing its flagship product, an anti-HIV microbicide called 5P12-RANTES, into the clinic.